All Type of News
Leading pharmaceutical firms’ sales up 11.5% in second quarter
The combined sales of the 10 major domestic pharmaceutical manufacturers in the second quarter of this year marked a growth rate of 11.5 percent, while their combined operating income plunged by 1.2 percent, according...
AIDS patients group urging Roche Korea to supply FuzeonA group of 10 members of a AIDS patients group staged a rally to protest against delay of Fuzeon, a new anti-AIDS medicine, in the Roche Korea headquarters in Seoul.
These me...
|
.jpg)
Pharmaceutical firms' business model failingThe "blockbuster" business model of pharmaceutical companies is failing, according to Sang-Won Lee, senior researcher of Korea Health Industry Development Institute.
Lee said...
|
Chemically modified clopidogrel is on domestic marketHanmi Pharm says its chemically modified clopidogrel “Pidogle (clopidogrel napadisilate) tablets” are available in the domestic anti-clogging medicines market.
“We expect a p...
|
First generic Fosamax available on marketKwangdong Pharm says it has launched its generic version of Fosamax (alendronate) tablets, which are taken once a week.
"These approvals will provide generic options for pati...
|
Pharmaceutical makers brace for supermarket’s selling
The majority of OTC markers are considering selling medicines in supermarkets and drugstores if the government allows them to do so.
Outwardly, these pharmaceutical companies are voicing an opposition to supermarke...
Unified OTC distribution attracts leading drug makers
More and more pharmaceutical companies are focusing on unified distribution of their flagship products by associate wholesalers in the midst of stagnant OTC sales.
Market sources say pharmaceutical companies will b...
KFDA approves Cialis 5mg
The Korea Food and Drug Administration has approved Eli Lilly and Company's Cialis (tadalafil) for once daily use (5 mg), an oral medication taken once per day to treat erectile dysfunction (ED). When Cialis for once ...
Doctors protest new prescription planDoctors are opposing a new rule which they claim will reduce their voice in patients' choices of pharmaceuticals.
Under the new plan, medical doctors will have to make prescr...
|
Swedish drug pricing and reimbursement policies outlinedThanks to low mark-ups in the distribution chain and no VAT for prescribed medicines, Sweden’s public prices for pharmaceuticals are relatively low, in contrast to average price...
|
